Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells

被引:24
作者
Berthier-Vergnes, O [1 ]
Gaucherand, M
Péguet-Navarro, J
Plouet, J
Pageaux, JF
Schmitt, D
Staquet, MJ
机构
[1] Hop Edouard Herriot, INSERM, U346, F-69437 Lyon, France
[2] UPR CNRS 9062 IPBS, F-31077 Toulouse, France
[3] Inst Natl Sci Appl, INSERM, U352, F-69621 Villeurbanne, France
关键词
human melanoma; Langerhans cell; differentiation; maturation;
D O I
10.1054/bjoc.2001.2183
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Tumour-derived factors suppress differentiation and function of in vitro generated DC. Here, we investigate the effect of two melanoma clones differing in their invasive and metastatic properties on the generation and/or functional maturation of human epidermal LC. LC were generated from CD34(+) cord blood progenitors under GM-CSF/TNF-alpha/TGF-beta1. CD34(+) cells were co-cultured with or without melanoma cells using Transwell dishes. After 11 days of co-culture, CD34(+)-derived cells display a non-adherent undifferentiated morphology, a high level of monocytic CD14 marker, a down-regulated expression of LC markers (CD1a, E-cadherin) and DC markers (CD40, CD80, CD54. CD58, CD83, CD86, HLA-DR, HLA-class 1). These cells were less potent than control LC in inducing allogeneic T cell proliferation. The generation of the CD14(+) population was correlated with a decrease in the CD1a(+) population, without any statistical differences between the two clones. Melanoma cells diverted the differentiation of CD34(+) cells towards a dominant CD14(+) population only if the progenitors were in an early growth phase. IL-10, TGF-beta1 and VEGF were not responsible for these effects, as assessed by using blocking antibodies. By contrast, co-culture of fresh epidermal LC with melanoma cells did not affect their phenotype and function, Our data demonstrate that melanoma cells inhibit the earliest steps of LC differentiation, but failed to affect the functional maturation of epidermal LC. This suggests that melanoma cells participate in their own escape from immunosurveillance by preventing LC generation in the local cutaneous microenvironment. (C) 2001 Cancer Research Campaign.
引用
收藏
页码:1944 / 1951
页数:8
相关论文
共 31 条
[1]
Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]
Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII [J].
Bechetoille, N ;
Haftek, M ;
Staquet, MJ ;
Cochran, AJ ;
Schmitt, D ;
Berthier-Vergnes, O .
MELANOMA RESEARCH, 2000, 10 (05) :427-434
[3]
EXPRESSION OF PEANUT AGGLUTININ-BINDING GLYCOCONJUGATES IN PRIMARY MELANOMAS WITH HIGH-RISK OF METASTASES [J].
BERTHIERVERGNES, O ;
ZEBDA, N ;
BAILLY, M ;
BAILLY, C ;
DORE, JF ;
THOMAS, L ;
COCHRAN, AJ .
LANCET, 1993, 341 (8855) :1292-1292
[4]
INTERLEUKIN-10 INHIBITS T-CELL ALLOREACTION INDUCED BY HUMAN DENDRITIC CELLS [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
BARTHELEMY, C ;
LIU, YJ ;
BANCHEREAU, J .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (08) :1177-1185
[5]
Respective involvement of TGF-β and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors [J].
Caux, C ;
Massacrier, C ;
Dubois, B ;
Valladeau, J ;
Dezutter-Dambuyant, C ;
Durand, I ;
Schmitt, D ;
Saeland, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (05) :781-791
[6]
CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha [J].
Caux, C ;
Vanbervliet, B ;
Massacrier, C ;
DezutterDambuyant, C ;
deSaintVis, B ;
Jacquet, C ;
Yoneda, K ;
Imamura, S ;
Schmitt, D ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :695-706
[7]
GM-CSF AND TNF-ALPHA COOPERATE IN THE GENERATION OF DENDRITIC LANGERHANS CELLS [J].
CAUX, C ;
DEZUTTERDAMBUYANT, C ;
SCHMITT, D ;
BANCHEREAU, J .
NATURE, 1992, 360 (6401) :258-261
[8]
Enk AH, 1997, INT J CANCER, V73, P309, DOI 10.1002/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.3.CO
[9]
2-B
[10]
Tumor's other immune targets: dendritic cells [J].
Esche, C ;
Lokshin, A ;
Shurin, GV ;
Gastman, BR ;
Rabinowich, H ;
Watkins, SC ;
Lotze, MT ;
Shurin, MR .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (02) :336-344